What was the market valuation of the US electronic pill market in 2024?

The market valuation was $891.8 Million in 2024. Read More

What is the projected market valuation for the US electronic pill market by 2035?

The projected market valuation for 2035 is $1797.63 Million. Read More

What is the expected CAGR for the US electronic pill market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 6.58%. Read More

Which application segments contributed to the US electronic pill market in 2024?

In 2024, the application segments included Capsule Endoscopy at $200.0 - $400.0 Million, Drug Delivery at $300.0 - $600.0 Million, and Patient Monitoring at $391.8 - $797.63 Million. Read More

What are the target areas for electronic pills in the US market?

The target areas include Esophagus at $100.0 - $200.0 Million, Stomach at $200.0 - $400.0 Million, Small Intestine at $300.0 - $600.0 Million, and Large Intestine at $291.8 - $597.63 Million. Read More

What components are involved in the production of electronic pills?

Key components include biocompatible capsule encasing microsensors at $267.54 - $540.0 Million, control chip at $178.62 - $360.0 Million, radio transmitter at $178.62 - $360.0 Million, and power source at $267.54 - $537.63 Million. Read More

Who are the key players in the US electronic pill market?

Key players include Proteus Digital Health, Otsuka Pharmaceutical, Medtronic, Abbott Laboratories, Eli Lilly and Company, Novartis, GSK, Boehringer Ingelheim, and AstraZeneca. Read More

What end-user segments are driving the US electronic pill market?

End-user segments include Hospitals at $267.5 - $550.0 Million, Diagnostic Centers at $178.5 - $360.0 Million, Clinical Research Organizations at $178.5 - $360.0 Million, and Medical Centers at $267.3 - $527.63 Million. Read More

How does the US electronic pill market compare to other regions?

While specific regional comparisons are not provided, the US market is characterized by a robust valuation and a strong growth trajectory. Read More

What trends are influencing the growth of the US electronic pill market?

Trends influencing growth include advancements in drug delivery systems, increased patient monitoring capabilities, and the integration of technology in healthcare. Read More

US Electronic Pill Market

ID: MRFR/HCIT/17811-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

US Electronic Pill Market Research Report By Application (Capsule Endoscopy, Drug Delivery) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Construction, BY Application (USD Million)
  1. 4.1.1 Capsule Endoscopy
  2. 4.1.2 Drug Delivery
  3. 4.1.3 Patient Monitoring
2. 4.2 Construction, BY Target area (USD Million)
  1. 4.2.1 Esophagus
  2. 4.2.2 Stomach
  3. 4.2.3 Small Intestine
  4. 4.2.4 Large Intestine
3. 4.3 Construction, BY Parts (USD Million)
  1. 4.3.1 Biocompatible capsule encasing microsensors
  2. 4.3.2 Control chip
  3. 4.3.3 Radio transmitter
  4. 4.3.4 Power source
4. 4.4 Construction, BY End-User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Diagnostic Centers
  3. 4.4.3 Clinical Research Organizations
  4. 4.4.4 Medical Centers
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Construction
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Proteus Digital Health (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Otsuka Pharmaceutical (JP)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Medtronic (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Abbott Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Eli Lilly and Company (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Novartis (CH)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 GSK (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Boehringer Ingelheim (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 AstraZeneca (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY TARGET AREA
4. 6.4 US MARKET ANALYSIS BY PARTS
5. 6.5 US MARKET ANALYSIS BY END-USER
6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CONSTRUCTION
9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
12. 6.12 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
13. 6.13 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 CONSTRUCTION, BY TARGET AREA, 2024 (% SHARE)
15. 6.15 CONSTRUCTION, BY TARGET AREA, 2024 TO 2035 (USD Million)
16. 6.16 CONSTRUCTION, BY PARTS, 2024 (% SHARE)
17. 6.17 CONSTRUCTION, BY PARTS, 2024 TO 2035 (USD Million)
18. 6.18 CONSTRUCTION, BY END-USER, 2024 (% SHARE)
19. 6.19 CONSTRUCTION, BY END-USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TARGET AREA, 2025-2035 (USD Million)
  3. 7.2.3 BY PARTS, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Construction Market Segmentation

Construction By Application (USD Million, 2025-2035)

Capsule Endoscopy
Drug Delivery
Patient Monitoring

Construction By Target area (USD Million, 2025-2035)

Esophagus
Stomach
Small Intestine
Large Intestine

Construction By Parts (USD Million, 2025-2035)

Biocompatible capsule encasing microsensors
Control chip
Radio transmitter
Power source

Construction By End-User (USD Million, 2025-2035)

Hospitals
Diagnostic Centers
Clinical Research Organizations
Medical Centers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”